Awh Capital, L.P. Reata Pharmaceuticals Inc Transaction History

Awh Capital, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jun 14, 2023	SELL	$20.71 - $36.5 $207,100 - $365,000	-10,000 Reduced 13.33%	65,000 $1.98 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $207,100 - $365,000	-10,000 Reduced 13.33%	65,000 $1.98 Million
Q1 2022 Jun 14, 2023	BUY	$24.12 - $39.6 $1.81 Million - $2.97 Million	75,000 New	75,000 $2.46 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $1.81 Million - $2.97 Million	75,000 New	75,000 $2.46 Million
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $969,285 - $1.75 Million	-9,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $888,535 - $1.55 Million	9,500 New	9,500 $925,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Awh Capital, L.P., based on Form 13F filings with the SEC.

Stay updated on Awh Capital, L.P. with notifications on news.